Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-04
1991-10-22
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 540492, 544125, 544333, 546174, 546176, C07D40112, C07D40512, A61K 3147, A61K 31505
Patent
active
050596098
ABSTRACT:
Substituted tetralins, chromans and related compounds which, by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction and related disease states in mammals, pharmaceutical compositions thereof, a method of treatment therewith, and to intermediates useful in the synthesis thereof.
REFERENCES:
patent: 4183945 (1980-01-01), Doria et al.
patent: 4202985 (1980-05-01), Hoehn
patent: 4363811 (1982-12-01), Evans et al.
patent: 4576949 (1986-03-01), Smith
patent: 4661499 (1987-04-01), Young et al.
patent: 4661596 (1987-09-01), Kreft, III et al.
Eggler James F.
Marfat Anthony
Melvin, Jr. Lawrence S.
Blackwood Robert K.
Lumb J. Trevor
Pfizer Inc.
Richardson Peter C.
Springer David B.
LandOfFree
Substituted tetralins, chromans and related compounds in the tre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetralins, chromans and related compounds in the tre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetralins, chromans and related compounds in the tre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108756